| Organism name | Xylopia parviflora |
|---|---|
| Genus | Xylopia |
| Family | Annonaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Xylopia parviflora |
|---|---|
| Linked NCBI taxonomy ID | 992813 |
| Linked level | species |
| Family in NCBI taxonomy | Annonaceae |
|---|---|
| ID | 22140 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | Magnoliophyta |
|---|---|
| ID | 3398 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00001806
|
Anolobine
/ (-)-Anolobine |
CHEMBL257746
|
No. 20 | No. 4 |
|
|||
|
C00001807
|
Anonaine
/ (-)-Anonaine / (R)-Annonaine |
CHEMBL401798
|
C098138
|
1 / 0 / 0 | No. 20 | No. 4 |
|
|
|
C00034986
|
(+)-Noroconovine
|
No. 20 | No. 4 |
|
||||
|
C00034984
|
(+)-10,11-Dihydroxy-1,2-dimethoxynoraporphine
|
No. 20 | No. 4 |
|
||||
|
C00034982
|
(+)-1,2-Dimethoxy-3-hydroxy-9,10-methylenedioxynoraporphine
|
CHEMBL1618043
|
No. 20 | No. 4 |
|
|||
|
C00027433
|
Laurolitsine
/ (+)-Norboldine / (+)-Laurolitsine |
CHEMBL487388
|
C109133
|
No. 20 | No. 4 |
|
||
|
C00027409
|
Laurotetanin
/ Laurotetanine / (+)-Laurotetanine |
CHEMBL464098
|
C008256
|
No. 20 | No. 4 |
|
||
|
C00027307
|
Calycinine
/ (-)-Calycinine |
CHEMBL226824
|
No. 20 | No. 4 |
|
|||
|
C00025676
|
Norglaucin
/ Norglaucine / (+)-Norglaucine / O,O-Dimethyllaurelliptine |
No. 20 | No. 4 |
|
||||
|
C00025675
|
Lauroscholtzine
/ 2-O-Methylboldine / N-Methyllaurotetanine / (+)-N-Methyllaurotetanine |
CHEMBL464099
|
1 / 1 / 0 | No. 20 | No. 4 |
|
||
|
C00025269
|
Nornantenine
/ N-Nornantenine / (+)-Nornantenine |
CHEMBL1254951
|
1 / 0 / 0 | No. 20 | No. 4 |
|
||
|
C00027304
|
Boldine
/ d-Boldine / (+)-Boldine |
CHEMBL388342
CHEMBL1321247 CHEMBL1437753 |
C011686
|
34 / 32 / 35 | No. 20 | No. 4 |
|
|
|
C00025655
|
Corytuberine
/ (+)-Corytuberine |
CHEMBL227965
|
C013896
|
1 / 0 / 0 | No. 20 | No. 4 |
|
|
|
C00001928
|
Xylopine
/ (-)-Xylopine |
CHEMBL227689
CHEMBL452201 |
C062700
|
No. 20 | No. 4 |
|
||
|
C00025402
|
Norargemonine
/ (-)-Norargemonine / O2-Demetylargemonie / O8-Demethylargemonine |
CHEMBL1570385
|
2 / 2 / 0 | No. 37 | No. 4 |
|
||
|
C00025397
|
Rotundine
/ (-)-Bisnorargemonine |
CHEMBL518908
CHEMBL1494954 |
1 / 0 / 0 | No. 37 | No. 4 |
|
||
|
C00025238
|
Discretine
/ (-)-Discretine |
CHEMBL513084
|
No. 37 | No. 4 |
|
|||
|
C00025930
|
Lindoldhamine
/ (+)-Lindoldhamine |
CHEMBL1375576
|
9 / 8 / 11 | No. 89 | No. 4 |
|
||
|
C00027137
|
Dehydrocoreximine
|
No. 155 | No. 4 |
|
||||
|
C00001874
|
Neprotin
/ Neprotine / Yatrorizine / Jatrorrhizine |
CHEMBL251055
|
C055785
|
14 / 27 / 20 | 1 / 0 | No. 155 | No. 4 |
|
|
C00026127
|
Dehydrodiscretine
/ Pseudojatrorrhizine |
CHEMBL220527
|
No. 155 | No. 4 |
|
|||
|
C00027159
|
Depiline
/ Palmatine / Berbericinine / O,O-Dimethyldemethyleneberberine |
CHEMBL206106
|
C005413
|
8 / 13 / 13 | 8 / 0 | No. 155 | No. 4 |
|
|
C00027160
|
Phellodendrine
|
C079418
|
No. 234 |
|
||||
|
C00034979
|
(-)-4'-O-Methylcoclaurine
|
CHEMBL451723
|
No. 253 | No. 4 |
|
|||
|
C00025652
|
d-Coclaurine
/ Sanjoinine K / (R)-Coclaurine / (+)-Coclaurine / (+)-R-Coclaurine |
CHEMBL256448
CHEMBL453291 CHEMBL446211 |
8 / 17 / 10 | No. 253 | No. 4 |
|
||
|
C00025619
|
(-)-N-Methylcoclaurine
/ (R)-N-Methylcoclaurine |
CHEMBL453292
CHEMBL513109 |
No. 253 | No. 4 |
|
|||
|
C00001885
|
Escholin
/ Escholine / Thalictrin / Thalictrine / Magnoflorine / (+)-Magnoflorine |
CHEMBL235428
|
C001670
|
No. 286 | No. 4 |
|
||
|
C00027170
|
Xanthoplanine
/ (+)-Xanthoplanine |
CHEMBL1180065
|
No. 286 | No. 4 |
|
|||
|
C00025674
|
N-Methylcorydine
/ (+)-N-Methylcorydine |
CHEMBL1617951
|
No. 286 | No. 4 |
|
|||
|
C00027152
|
N-Methylphoebine
|
No. 286 | No. 4 |
|
||||
|
C00025654
|
Codamine
/ (+)-Codamine / L-(+)-Codamine / (S)-(+)-Codamine |
CHEMBL251624
|
No. 345 | No. 4 |
|
|||
|
C00025666
|
(S)-Laudanine
/ (+)-Laudanidine / L-(+)-Laudanidine |
CHEMBL251625
CHEMBL1425007 |
2 / 0 / 0 | No. 345 | No. 4 |
|
||
|
C00034987
|
(+)-Parvinine
|
CHEMBL452500
|
No. 345 | No. 4 |
|
|||
|
C00001910
|
Reticuline
/ (+)-Reticuline |
CHEMBL235212
CHEMBL401501 CHEMBL464734 |
C003298
|
1 / 0 / 0 | No. 345 | No. 4 |
|
|
|
C00026017
|
Protosinomenine
/ (S)-Protosinomenine |
No. 345 | No. 4 |
|
||||
|
C00001862
|
Glaziovine
/ L-Glaziovine / N-Methylcrotsparine / L-(-)-N-Methylcrotsparine |
CHEMBL1980854
|
C007847
|
No. 688 |
|
|||
|
C00025272
|
Stepharine
/ (+)-Stepharine |
CHEMBL463957
CHEMBL1975436 |
C009320
|
No. 688 |
|
|||
|
C00025934
|
Lotusine
/ (-)-Lotusine / D-(-)-Lotusine |
No. 896 |
|
|||||
|
C00025982
|
Oblongine
/ (+)-Oblongine |
CHEMBL457373
|
C081049
|
No. 896 |
|
|||
|
C00025347
|
Tembetarine
/ (+)-Tembetarine |
C003383
|
No. 896 |
|
||||
|
C00035166
|
Yuzirine
|
C417577
|
No. 1137 |
|
||||
|
C00027167
|
Thalifoline
|
CHEMBL1813177
|
No. 2199 |
|
||||
|
C00027111
|
1,2-Dehydroreticuline
|
No. 2440 |
|
|||||
|
C00001879
|
Longifolonine
|
No. 3542 |
|
|||||
|
C00001815
|
Backebergine
|
No. 4224 |
|
|||||
|
C00026021
|
Pycnarrhine
/ Dehydrocorypalline |
CHEMBL1618006
|
No. 4925 |
|
||||
|
C00027140
|
Dihydrobackebergine
/ 3,4-Dihydrobackebergine / 3,4-Dihydro-6,7-dimethoxyisoquinoline / 6,7-Dimethoxy-3,4-dihydroisoquinoline |
CHEMBL1998359
|
No. 4925 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| O75496 | Geminin | Unclassified protein | C00025402 C00025652 C00025666 C00027304 | 0 / 0 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001874 C00025397 C00025652 C00025666 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001874 C00025652 C00025930 C00027304 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001874 C00025652 C00025930 C00027304 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001874 C00025652 C00025930 C00027304 | 4 / 3 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001874 C00027159 C00027304 | 11 / 10 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001874 C00027159 C00027304 | 0 / 1 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00027159 C00027304 | 0 / 1 |
| P04062 | Glucosylceramidase | Enzyme | C00001874 C00025652 | 6 / 4 |
| P14618 | Pyruvate kinase PKM | Enzyme | C00025652 C00025930 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00025930 C00027304 | 2 / 5 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00001874 C00027304 | 1 / 1 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00025930 C00027304 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00001874 C00027304 | 0 / 0 |
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001874 C00027304 | 1 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00025930 C00027304 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00027159 C00027304 | 1 / 1 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00027159 C00027304 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001874 C00027304 | 0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00027159 C00027304 | 0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00025930 C00027304 | 1 / 2 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00027159 C00027304 | 1 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00027304 | 1 / 1 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00025652 | 7 / 3 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00027304 | 0 / 0 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00025402 | 2 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00027159 | 0 / 0 |
| P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00027304 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00027304 | 0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00027304 | 3 / 3 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00027304 | 2 / 2 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00027304 | 0 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00025269 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001910 | 0 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00027304 | 0 / 0 |
| Q14761 | Protein tyrosine phosphatase receptor type C-associated protein | Enzyme | C00001807 | 0 / 0 |
| P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00027304 | 1 / 1 |
| P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00027304 | 1 / 1 |
| P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00025655 | 0 / 0 |
| P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00025675 | 1 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00027304 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00027304 | 0 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00001874 | 0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00025930 | 1 / 1 |
| Q99700 | Ataxin-2 | Unclassified protein | C00027304 | 1 / 1 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00027304 | 0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00027304 | 1 / 4 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00001874 | 4 / 1 |
| P43351 | DNA repair protein RAD52 homolog | Unclassified protein | C00001874 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00001874
C00027159
|
| 6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00027159
|
| 6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00027159
|
| 6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00027159
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00027159
|
| 3570 | IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80 | interleukin 6 receptor |
C00027159
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00027159
|
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00027159
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #114500 | Colorectal cancer; crc |
P84022
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
| #605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) |
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|